Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-10 Sale | 2024-04-12 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 7,500 | $26.85 | $201,392 | 45,723 (Direct) | View |
| 2024-04-01 Sale | 2024-04-03 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 12,495 | $31.23 | $390,208 | 17,728 (Direct) | View |
| 2024-03-12 Sale | 2024-03-14 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 4,067 | $25.03 | $101,815 | 106,502 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 25,933 | $25.03 | $649,205 | 203,193 (Direct) | View |
| 2022-12-09 Sale | 2022-12-13 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 13,969 | $28.43 | $397,193 | 148,243 (Direct) | View |
| 2022-12-07 Sale | 2022-12-09 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 23,648 | $21.85 | $516,782 | 210,111 (Direct) | View |
| 2022-11-30 Sale | 2022-12-02 7:00 pm | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 85 | $19.06 | $1,620 | 98,253 (Direct) | View |
| 2022-11-23 Sale | 2022-11-28 5:00 pm | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 1,261 | $19.07 | $24,048 | 98,338 (Direct) | View |
| 2022-11-18 Sale | 2022-11-22 8:00 pm | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 1,037 | $19.43 | $20,151 | 295,227 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-10 Exercise | 2024-04-12 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 7,500 | $2.14 | 45,723 (Direct) | View |
| 2024-04-10 Exercise | 2024-04-12 6:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 7,500 | $0 | 45,723 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 12,495 | $2.14 | 17,728 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 6:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 12,495 | $0 | 17,728 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-14 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 4,067 | $2.14 | 106,502 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-14 6:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 4,067 | $0 | 106,502 (Direct) | View |
| 2024-03-07 Exercise | 2024-03-11 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 25,933 | $2.14 | 203,193 (Direct) | View |
| 2024-03-07 Exercise | 2024-03-11 6:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 25,933 | $0 | 203,193 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-24 6:00 pm | N/A 2034-01-21 | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 66,586 | $0 | 66,586 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-08 6:10 pm | N/A 2033-02-06 | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 85,000 | $0 | 85,000 (Direct) | View |
| 2022-12-09 Exercise | 2022-12-13 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 13,969 | $2.14 | 148,243 (Direct) | View |
| 2022-12-09 Exercise | 2022-12-13 6:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 13,969 | $0 | 148,243 (Direct) | View |
| 2022-12-07 Exercise | 2022-12-09 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 23,648 | $2.14 | 210,111 (Direct) | View |
| 2022-12-07 Exercise | 2022-12-09 6:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 23,648 | $0 | 210,111 (Direct) | View |
| 2022-11-30 Exercise | 2022-12-02 7:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 85 | $2.14 | 98,253 (Direct) | View |
| 2022-11-30 Exercise | 2022-12-02 7:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 85 | $0 | 98,253 (Direct) | View |
| 2022-11-23 Exercise | 2022-11-28 5:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 1,261 | $2.14 | 98,338 (Direct) | View |
| 2022-11-23 Exercise | 2022-11-28 5:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 1,261 | $0 | 98,338 (Direct) | View |
| 2022-11-18 Exercise | 2022-11-22 8:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 1,037 | $2.14 | 295,227 (Direct) | View |
| 2022-11-18 Exercise | 2022-11-22 8:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 1,037 | $0 | 295,227 (Direct) | View |
| 2021-12-14 Option Award | 2021-12-16 6:00 pm | N/A 2031-12-13 | Aerovate Therapeutics Inc. | AVTE | Eldridge George A See Remarks | 65,433 | $0 | 65,433 (Direct) | View |
| 2021-04-02 Option Award | 2021-07-01 6:29 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Eldridge George A See Remarks | 226,426 | $0 | 226,426 (Direct) | View |
Ownership | 2021-06-29 7:39 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Eldridge George A See Remarks | 0 | $0 | 149,526 (Direct) | View |